| 10556943 |
HLA-DR binding peptides and their uses |
Keith L. Knutson, Mary L. Disis, Melanie Beebe, Glenn Ishioka |
2020-02-11 |
| 9913884 |
HLA-A2 tumor associated antigen peptides and compositions |
Glenn Ishioka, Alessandro Sette, Robert Chesnut |
2018-03-13 |
| 9394350 |
HLA-A2 tumor associated antigen peptides and compositions |
Glen Ishioka, Alessandro Sette, Robert Chesnut |
2016-07-19 |
| 8741576 |
Heteroclitic analogs and related methods |
Shabnam Tangri, Alessandro Sette, Glenn Ishioka |
2014-06-03 |
| 8007810 |
HLA-A2 tumor associated antigen peptides and compositions |
Glenn Ishioka, Alessandro Sette, Robert Chesnut |
2011-08-30 |
| 6602510 |
HLA class I A2 tumor associated antigen peptides and vaccine compositions |
Alessandro Sette, John Sidney, Scott Southwood, Esteban Celis, Elissa Keogh +1 more |
2003-08-05 |
| 6534482 |
Expression vectors for stimulating an immune response and methods of using the same |
Gary G. Hermanson, Alessandro Sette, Glenn Ishioka, Brian D. Livingston, Robert Chesnut |
2003-03-18 |
| 6464980 |
MAGE-1 c-terminal immunogenic peptides |
Brian D. Livingston, Alessandro Sette, John Sidney |
2002-10-15 |
| 5750395 |
DNA encoding MAGE-1 C-terminal cytotoxic t lymphocyte immunogenic peptides |
Brian D. Livingston, Alessandro Sette, John Sidney |
1998-05-12 |